Skip to content

Study on the impact of test food consumption on sleep

Study on the impact of test food consumption on sleep - Study on the impact of test food consumption on sleep

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053313
Enrollment
20
Registered
2025-03-31
Start date
2024-01-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Oral ingestion of the test food for 4 weeks Oral ingestion of the pracebo food for 4 weeks

Sponsors

Nippon Sport Science University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Individuals who are healthy sports athletes, aged 18 and above at the time of consent acquisition. 2) Individuals who have received enough explanation and understood about this study, and who can obtain informed consent.

Exclusion criteria

Exclusion criteria: 1)Individuals who cannot provide consent to participate in the study. 2)Individuals currently undergoing treatment for a serious illness. 3)Individuals unable to perform adequate training at the start of the study due to injuries or other reasons. 4)Individuals scheduled for surgery during the study period. 5)Individuals who have received inpatient treatment within the past six months or are planning hospitalization during the trial. 6)Individuals who regularly use medications during the study period. 7)Individuals participating in other clinical research or who have not completed a one-month period after participating in a clinical trial. 8)Individuals who regularly consume supplements rich in polyphenols outside of their diet. 9)Individuals who cannot avoid alcohol from two days before the trial starts until its completion. 10)Individuals with a habit of consuming more than 20g of pure alcohol per day, more than five days a week. 11)Individuals with a smoking habit. 12)Individuals with irregular sleep hours and habits. 13)Individuals currently receiving treatment for, or with a history of, psychiatric disorders (such as depression) or sleep disorders. 14)Individuals diagnosed with sleep apnea syndrome or aware of their own apnea episodes. 15)Individuals with symptoms of nocturia, or those under medication for non-urinary tract diseases. 16)Individuals with allergies to medications or food. 17)Individuals with metal allergies (skin troubles due to electrodes) or sensitive skin. 18)Individuals considered by the research director to be unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Sleep-related questionnaire

Secondary

MeasureTime frame
VAS (fatigue, wakefulness), assessment of sleep status, fluctuations in glucose levels

Countries

Japan

Contacts

Public ContactMasaaki Sugita

Nippon Sport Science University School of Physical Education

m-sugita@nittai.ac.jp03-5706-1148

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026